Trial
NCT04417257
Study of LAU-7b for the Treatment of Coronavirus Disease 2019 (COVID-19) Disease in Adults
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Laurent Pharmaceuticals Inc.
Collaborators
—
Condition
COVID-19 Disease
Intervention
LAU-7b
Why stopped
Phase 2 completed normally, Phase 3 terminated for futility due to lack of aggravation events.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-11-13